Developing antibacterial peptides as a promising therapy for combating antibiotic-resistant Pseudomonas aeruginosa infections
-
Published:2024-06
Issue:
Volume:
Page:1259-1264
-
ISSN:2231-0916
-
Container-title:Veterinary World
-
language:en
-
Short-container-title:Vet World
Author:
Darwish Rula M.1ORCID, Salama Ali H.2ORCID
Affiliation:
1. Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, the University of Jordan, Amman, 11942, Jordan. 2. Department of Pharmacy, Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan.
Abstract
Background and Aim: Antibiotic-resistant Pseudomonas aeruginosa poses a serious health threat. This study aimed to investigate the antibacterial activity of peptide KW-23 against drug-resistant P. aeruginosa and its potential for enhancing the efficacy of conventional antibiotics.
Materials and Methods: KW-23 was synthesized from nine amino acids, specifically three tryptophans and three lysines. The purity of the substance was analyzed using reverse-phase high-performance liquid chromatography. The peptide was identified through mass spectrometry using electrospray ionization. The minimum inhibitory concentration (MIC) values of KW-23 in combination with conventional antibiotics against control and multidrug-resistant P. aeruginosa were determined utilizing broth microdilution. The erythrocyte hemolytic assay was used to measure toxicity. The KW-23 effect was analyzed using the time-kill curve.
Results: The peptide exhibited strong antibacterial activity against control and multidrug-resistant strains of P. aeruginosa, with MICs of 4.5 μg/mL and 20 μg/mL, respectively. At higher concentration of 100 μg/mL, KW-23 exhibited a low hemolytic impact, causing no more than 3% damage to red blood. The cytotoxicity assay demonstrates KW-23’s safety, while the time-kill curve highlights its rapid and sustained antibacterial activity. The combination of KW-23 and gentamicin exhibited synergistic activity against both susceptible and resistant P. aeruginosa, with fractional inhibitory concentration index values of 0.07 and 0.27, respectively.
Conclusion: The KW-23 synthesized in the laboratory significantly combats antibiotic-resistant P. aeruginosa. Due to its strong antibacterial properties and low toxicity to cells, KW-23 is a promising alternative to traditional antibiotics in combating multidrug-resistant bacteria.
Keywords: antimicrobial resistance, peptides, Pseudomonas aeruginosa, synergism.
Publisher
Veterinary World
Reference33 articles.
1. Grosso-Becerra, M.V., Santos-Medellìn, C., GonzàlezValdez, A., Mendèz, J.L., Delgado, G., Morales-Espinosa, R., Servìn-Gonzàlez, L., Alcaraz, L.D. and Soberòn-Chàvez, G. (2014) Pseudomonas aeruginosa clinical and environmental isolates constitute a single population with high phenotypic diversity. BMC Genomics, 15: 318. 2. Ludwig, C., de Jong, A., Moyaert, H., El Garch, F., Janes, R., Klein, U., Morrisey, I., Thiry, J. and Youala, M. (2016) Antibacterial susceptibility monitoring of dermatological bacterial pathogens isolated from diseased dogs and cats across Europe (ComPath results). J. Appl. Microbiol., 121(5): 1254–1267. 3. Hall, J.L., Holmes, M.A. and Baines, S.J. (2013) Prevalence and antibacterial resistance of canine urinary tract pathogens. Vet. Rec., 173(22): 549. 4. Yoshimura, F. and Nikaido, H. (1982) Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J. Bacteriol., 152(2): 636–642. 5. Aeschlimann, J.R. (2003) The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy, 23(7): 916–924.
|
|